Dec 1, 2025 08:51AM Truist Securities Starts Immunome Inc. (IMNM) at Buy

Nov 17, 2025 07:08AM Immunome Inc. (IMNM) PT Raised to $33 at Stephens

Nov 7, 2025 07:46AM Immunome, Inc. (IMNM) Misses Q3 EPS by 8c

Oct 23, 2025 12:01PM Immunome presents data on cancer drug payload overcoming resistance

Sep 22, 2025 06:15AM Goldman Sachs Starts Immunome Inc. (IMNM) at Buy

Sep 18, 2025 08:02AM Infinimmune partners with Immunome for antibody discovery research

Sep 5, 2025 07:11AM Craig-Hallum Starts Immunome Inc. (IMNM) at Buy

Jul 28, 2025 08:31AM ASP Isotopes invests $5 million in radiotherapeutic startup IsoBio

May 19, 2025 07:03AM D. Boral Capital Downgrades Immunome Inc. (IMNM) to Hold 'Pending Financial Clarity'

May 12, 2025 04:27PM Immunome, Inc. (IMNM) Tops Q1 EPS by 14c

Mar 20, 2025 07:43AM Immunome Inc. (IMNM) PT Lowered to $25 at Guggenheim

Jan 30, 2025 07:22AM Immunome Inc. (IMNM) Prices Upsized Public Offering of Common Stock at $7.75/Each

Jan 29, 2025 04:27PM Immunome Inc. (IMNM) Announces Proposed $125M Share Offering

Nov 14, 2024 01:42PM Piper Sandler Reiterates Overweight Rating on Immunome Inc. (IMNM)

Nov 13, 2024 06:07PM Immunome, Inc. (IMNM) Misses Q3 EPS by 24c

Oct 8, 2024 04:34PM Immunome Inc. (IMNM) Files for 230.4K Share Offering by Selling Stockholders

Oct 8, 2024 08:05AM Immunome (IMNM) Appoints Roee Shahar as EVP, Commercial

Sep 16, 2024 08:54AM TD Cowen Reiterates Buy Rating on Immunome Inc. (IMNM)

Aug 13, 2024 09:49AM TD Cowen Reiterates Buy Rating on Immunome Inc. (IMNM)

Aug 13, 2024 09:12AM Immunome Inc. (IMNM) PT Lowered to $23 at Piper Sandler

Aug 13, 2024 07:04AM Immunome, Inc. (IMNM) Misses Q2 EPS by 22c

Jul 25, 2024 07:31AM Immunome (IMNM) Licenses Novel Antibodies from Nectin Therapeutics

Jun 27, 2024 08:03AM Immunome Inc. (IMNM) Appoints Phil Tsai as CTO